CPT code 21558 represents an extensive surgical excision of a malignant soft tissue tumor (for example, a sarcoma) located in the neck or anterior thorax with tumor and margin measurements of 5 cm or greater. This code is used for wide local resections that extend beyond the tumor to include surrounding structures suspected of involvement. Nationally, accurate coding for large soft tissue malignancy excisions is important for clinical documentation, correct claim processing, and alignment with surgical oncology practice standards.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for using this code, the typical service setting, and the payer landscape addressed in the publication. The report covers benchmarking around utilization and reimbursement patterns, relevant policy and coverage considerations that affect claim adjudication, and coding nuances that influence clinical documentation requirements. Data not available in the input will be clearly noted where applicable. The content aims to inform coding, billing, and administrative stakeholders about the appropriate clinical use and payer considerations for CPT code 21558 at a national level.